NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, Sidiq T, Shipp MA, Lizee GA, Kobayashi KS.
Yoshihama S, et al. Among authors: kobayashi ks.
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.
Proc Natl Acad Sci U S A. 2016.
PMID: 27162338
Free PMC article.